日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Impact of SARS-CoV-2 vaccines and recent chemotherapy on COVID-19 morbidity and mortality in patients with soft tissue sarcoma: an analysis from the OnCovid registry

SARS-CoV-2疫苗和近期化疗对软组织肉瘤患者COVID-19发病率和死亡率的影响:来自OnCovid注册研究的分析

Vincenzi, Bruno; Cortellini, Alessio; Mazzocca, Alessandro; Orlando, Sarah; Romandini, Davide; Aguilar-Company, Juan; Ruiz-Camps, Isabel; Valverde Morales, Claudia; Eremiev-Eremiev, Simeon; Tondini, Carlo; Brunet, Joan; Bertulli, Rossella; Provenzano, Salvatore; Bower, Mark; Generali, Daniele; Salazar, Ramon; Sureda, Anna; Prat, Aleix; Vasiliki, Michalarea; Van Hemelrijck, Mieke; Sita-Lumsden, Ailsa; Bertuzzi, Alexia; Rossi, Sabrina; Jackson, Amanda; Grosso, Federica; Lee, Alvin J X; Murphy, Cian; Belessiotis, Katherine; Mukherjee, Uma; Pommeret, Fanny; Loizidou, Angela; Gaidano, Gianluca; Dettorre, Gino M; Grisanti, Salvatore; Tucci, Marco; Fulgenzi, Claudia A M; Gennari, Alessandra; Napolitano, Andrea; Pinato, David J

A Phase I Trial of CT900, a Novel α-Folate Receptor-Mediated Thymidylate Synthase Inhibitor, in Patients with Solid Tumors with Expansion Cohorts in Patients with High-Grade Serous Ovarian Cancer

CT900(一种新型α-叶酸受体介导的胸苷酸合成酶抑制剂)在实体瘤患者中的I期临床试验,并纳入高级别浆液性卵巢癌患者作为扩展队列。

Banerjee, Susana; Michalarea, Vasiliki; Ang, Joo Ern; Ingles Garces, Alvaro; Biondo, Andrea; Funingana, Ionut-Gabriel; Little, Martin; Ruddle, Ruth; Raynaud, Florence; Riisnaes, Ruth; Gurel, Bora; Chua, Sue; Tunariu, Nina; Porter, Joanna C; Prout, Toby; Parmar, Mona; Zachariou, Anna; Turner, Alison; Jenkins, Ben; McIntosh, Stuart; Ainscow, Ed; Minchom, Anna; Lopez, Juanita; de Bono, Johann; Jones, Robert; Hall, Emma; Cook, Natalie; Basu, Bristi; Banerji, Udai

A phase I dose-escalation study of enzalutamide in combination with the AKT inhibitor AZD5363 (capivasertib) in patients with metastatic castration-resistant prostate cancer

一项恩扎卢胺联合AKT抑制剂AZD5363(capivasertib)治疗转移性去势抵抗性前列腺癌患者的I期剂量递增研究

Kolinsky, M P; Rescigno, P; Bianchini, D; Zafeiriou, Z; Mehra, N; Mateo, J; Michalarea, V; Riisnaes, R; Crespo, M; Figueiredo, I; Miranda, S; Nava Rodrigues, D; Flohr, P; Tunariu, N; Banerji, U; Ruddle, R; Sharp, A; Welti, J; Lambros, M; Carreira, S; Raynaud, F I; Swales, K E; Plymate, S; Luo, J; Tovey, H; Porta, N; Slade, R; Leonard, L; Hall, E; de Bono, J S

Phase I Trial of the PARP Inhibitor Olaparib and AKT Inhibitor Capivasertib in Patients with BRCA1/2- and Non-BRCA1/2-Mutant Cancers

PARP抑制剂奥拉帕尼和AKT抑制剂卡帕替尼治疗BRCA1/2突变型和非BRCA1/2突变型癌症患者的I期试验

Yap, Timothy A; Kristeleit, Rebecca; Michalarea, Vasiliki; Pettitt, Stephen J; Lim, Joline S J; Carreira, Suzanne; Roda, Desamparados; Miller, Rowan; Riisnaes, Ruth; Miranda, Susana; Figueiredo, Ines; Rodrigues, Daniel Nava; Ward, Sarah; Matthews, Ruth; Parmar, Mona; Turner, Alison; Tunariu, Nina; Chopra, Neha; Gevensleben, Heidrun; Turner, Nicholas C; Ruddle, Ruth; Raynaud, Florence I; Decordova, Shaun; Swales, Karen E; Finneran, Laura; Hall, Emma; Rugman, Paul; Lindemann, Justin P O; Foxley, Andrew; Lord, Christopher J; Banerji, Udai; Plummer, Ruth; Basu, Bristi; Lopez, Juanita S; Drew, Yvette; de Bono, Johann S

Neoadjuvant DCF vs. ACF for resectable oesophageal squamous cell carcinoma

可切除食管鳞状细胞癌的新辅助DCF方案与ACF方案的比较

Michalarea, Vasiliki; Smyth, Elizabeth C

Change in platelet levels during radiotherapy with concurrent and adjuvant temozolomide for the treatment of glioblastoma: a novel prognostic factor for survival

胶质母细胞瘤放疗联合同步及辅助替莫唑胺治疗期间血小板水平的变化:一种新的生存预后因素

Williams, Matt; Liu, Zi Wei; Woolf, David; Hargreaves, Sarah; Michalarea, Vasiliki; Menashy, Rebecca; Kooner, Ishminder; Wilson, Elena